Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-23T09:30:21.069Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroleptic-induced antinuclear antibodies

Published online by Cambridge University Press:  16 April 2020

JL Ayuso  and
J Saiz Ruiz
JL Ayuso
Affiliation:
Hospital Clínico de San Carlos, Universidad Complutense, Dipartamento de Psiquiatría, C/Martín Lagos s/n 28003, Madrid, Spain
J Saiz Ruiz
Affiliation:
Hospital Ramón y Cajal, Universidad de Alcalá, Servicio de Psiquiatría, Crta Colmenar Km 91, 28034Madrid, Spain

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the editor
Information
European Psychiatry , Volume 11 , Issue 7 , 1996 , pp. 378 - 379
Copyright
Copyright © Elsevier, Paris 1996

References

Ayuso, JLSaiz-Ruiz, JCasimiro, CPhenothiazine-induced antinuclear antibodies in psychiatric patients. IRCS Med Sci 1976; 4: 343Google Scholar
Berglund, CGSGottfries, CGGottfries, IStormby, KChlorpromazine-induced antinuclear factors. Acta Med Scand 1970; 187: 67–74CrossRefGoogle ScholarPubMed
Canoso, RTde, Oliveira RMNixon, RANeuroleptic-associated autoantibodies. A prevalence study. Biol Psychiatry 1990; 27: 863–870CrossRefGoogle ScholarPubMed
Gallien, MSchnetzler, JPMorin, JAnticorps antinucléaires et lupus induits par les phénothiazines chez six cents malades hospitalisés. Ann Med Psychol 1975; 2: 237–248Google Scholar
Spivak, BRadwan, MBartur, PMester, RWeizman, AAntinuclear autoantibodies in relation to bipolar affective disorder and lithium therapy. Eur Psychiatry 1996; 11: 50–52CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.